Citations as recorded by:

1. Neoalbaconol inhibits cell growth of human cholangiocarcinoma cells by up-regulating PTEN

Am J Transl Res, 2016, 8 p. 496

Citations as recorded by: PMC

2. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma

Tumor Biol., 2016, 37(3) p. 4159

DOI: 10.1007/s13277-015-4206-4

Citations as recorded by: Cross Ref

3. Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions

The American Journal of the Medical Sciences, 2016, 351(3) p. 259

DOI: 10.1016/j.amjms.2015.12.013

Citations as recorded by: Cross Ref

4. Histone Demethylase LSD1 Inhibitors Prevent Cell Growth by Regulating Gene Expression in Esophageal Squamous Cell Carcinoma Cells

Ann Surg Oncol, 2016, 23(1) p. 312

DOI: 10.1245/s10434-015-4488-1

Citations as recorded by: Cross Ref

5. Advances in the surgical treatment of hilar cholangiocarcinoma

Expert Review of Gastroenterology & Hepatology, 2015, 9(3) p. 369

DOI: 10.1586/17474124.2015.960393

Citations as recorded by: Cross Ref

6. Prognostic Factors of Cholangiocarcinoma After Surgical Resection: A Retrospective Study of 293 Patients

Med Sci Monit, 2015, 21 p. 2375

DOI: 10.12659/MSM.893586

Citations as recorded by: Cross Ref PMC

7. Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis

BioMed Research International, 2015, 2015 p. 1

DOI: 10.1155/2015/497942

Citations as recorded by: Cross Ref PMC

8. Use of an Autologous Liver Round Ligament Flap Zeros Postoperative Bile Leak after Curative Resection of Hilar Cholangiocarcinoma

PLoS ONE, 2015, 10(5) p. e0125977

DOI: 10.1371/journal.pone.0125977

Citations as recorded by: Cross Ref PMC